Beacon Therapeutics
Transforming Vision, Transforming Lives
95 employees · est. 2023 · London, United Kingdom
Fulcrum Therapeutics is the older company (2023 vs 2016).
Side-by-Side Comparison
| Metric | Beacon Therapeutics | Fulcrum Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2016 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Cambridge, United States |
| Employees | ||
| Employees | 95 | 74 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $341.00M | $603.30M |
| Funding Rounds | ||
| Funding Rounds | 4 | 8 |
| Services | ||
| Services | Not tracked yet | Modulating gene expression, Clinical trial development, Research and development in genetically defined diseases, Therapeutic innovation |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with sickle cell disease, Patients with beta-thalassemia, Healthcare providers, Medical researchers, Investors in biotech and pharmaceuticals |
| Taxonomy | ||
| Taxonomy | Ophthalmic Gene Therapy, Retinal Diseases, X-linked Retinitis Pigmentosa, AMD (age-related Macular Degeneration), Cone-rod Dystrophy, Gene Therapy Program, RPGR Gene, Clinical Trials, Target Generation Technology, Syncona, Oxford Science Enterprises, Inherited Retinal Diseases, Vision Restoration, Blindness | Biopharmaceutical, Rare Diseases, Genetic Diseases, Clinical Stage, Gene Expression Modulation, Drug Development, Neuromuscular Diseases, Cardiovascular Diseases, Losmapimod, Cambridge, Massachusetts, Proprietary Product Engine, Clinical Trials, Muscle-Wasting Disorders, Gene Regulation, FSHD |
| Website | ||
| Website | beacontx.com | fulcrumtx.com |
About Beacon Therapeutics
Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...
About Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company established in 2016 and based in the United States. It aims to enhance the lives of patients who suffer from genetically defined diseases, especially those in urgent need, with a primary focus on rare diseases. Positioned at the int...
We will tell you when either one moves
BounceWatch watches Beacon Therapeutics and Fulcrum Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Beacon Therapeutics and Fulcrum Therapeutics — by email.
Frequently Asked Questions
Compare Beacon Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and Fulcrum Therapeutics on 5 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
